P-MUC1C-ALLO1

· Poseida Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for P-MUC1C-ALLO1, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors [Phase 1]

See pricing